Open AccessPerformance of AHEAD Score in an Asian Cohort of Acute Heart Failure With Either Preserved or Reduced Left Ventricular Systolic Function
Author(s) -
Chen YuJen,
Sung ShihHsien,
Cheng HaoMin,
Huang WeiMing,
Wu ChungLi,
Huang ChiJung,
Hsu PaiFeng,
Yeh JongShiuan,
Guo ChaoYu,
Yu WenChung,
Chen ChenHuan
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.004297
Subject(s) - medicine , heart failure , ejection fraction , cardiology , atrial fibrillation , hazard ratio , diabetes mellitus , population , proportional hazards model , creatinine , renal function , confidence interval , endocrinology , environmental health
Background AHEAD (A: atrial fibrillation; H: hemoglobin; E: elderly; A: abnormal renal parameters; D: diabetes mellitus) score has been related to clinical outcomes of acute heart failure. However, the prognostic value of the AHEAD score in acute heart failure patients with either reduced or preserved left ventricular ejection fraction ( HF r EF and HF p EF ) remain to be elucidated. Methods and Results The study population consisted of 2143 patients (age 77±12 years, 68% men, 38% HF r EF ) hospitalized primarily for acute heart failure with a median follow‐up of 23.75 months. The performance of the AHEAD score (atrial fibrillation, hemoglobin <13 mg/dL for men and 12 mg/dL for women, age >70 years, creatinine >130 μmol/L, and diabetes mellitus) was evaluated by Cox's regression analysis for predicting cardiovascular and all‐cause mortality. The mean AHEAD scores were 2.7±1.2 in the total study population, 2.6±1.3 in the HF r EF group, and 2.7±1.1 in the HF p EF group. After accounting for sex, sodium, uric acid, and medications, the AHEAD score remained significantly associated with all‐cause and cardiovascular mortality (hazard ratio and 95% CI: 1.49, 1.38–1.60 and 1.48, 1.33–1.64), respectively. The associations of AHEAD score with mortality remained significant in the subgroups of HF r EF (1.63, 1.47–1.82) and HF p EF (1.34, 1.22–1.48). Moreover, when we calculated a new AHEAD ‐U score by considering uric acid (>8.6 mg/dL) in addition to the AHEAD score, the net reclassification was improved by 19.7% and 20.1% for predicting all‐cause and cardiovascular mortality, respectively. Conclusions The AHEAD score was useful in predicting long‐term mortality in the Asian acute heart failure cohort with either HF r EF or HF p EF . The new AHEAD ‐U score may further improve risk stratification.